Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The use of novel agents in the treatment of relapsed and refractory multiple myeloma.

The use of novel agents in the treatment of relapsed and refractory multiple myeloma. Leukemia. 2009 Dec; 23(12):2222-32.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.